from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0719/rplF

LFCtreatmentdescriptionclass of inhibitor

0.715

Amikacinug/mL Amikacintranslation

0.922

Cap5-10ug/mL Capreomycintranslation

1.383

Rox10-50 ug/mL Roxithromycintranslation

1.615

SM2-5 ug/mL Streptomycintranslation

1.732

Tet5-10 ug/mL Tetracyclinetranslation

0.544

Rif0.2-5ug/mL Rifampicintranscription

0.154

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.494

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-2.118

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.914

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.767

Clofazimine10-13 ug/mL Clofaziminerespiration

0.132

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-2.118

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-2.202

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.035

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.238

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.649

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.805

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.402

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.299

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.977

KCN5-20 ug/mL Potassium cyaniderespiration

-1.016

NaN30.2-2 mM Sodium aziderespiration

0.756

Nigericin50 uM Nigericinrespiration

-0.626

TRC10-150 ug/mL Triclosanrespiration

-1.695

TRZ10-25 ug/mL Thioridazinerespiration

-0.170

Valinomycin0.5-10 uM Valinomycinrespiration

0.619

ZnSO42 mM ZnSO4respiration

-0.061

menadione6-10 ug/mL Menadionerespiration

0.020

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.607

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.646

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.678

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.355

NRP_1Non-replicating persistence stage 1dosRassociated

0.841

Amp0.2mg/mL AmpicillincellWall

0.838

Cephalexin20-100 ug/mL CephalexincellWall

0.657

Cerulenin0.32-5 ug/mL CerulenincellWall

0.955

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.509

EMB10-20 ug/mL EthambutolcellWall

0.320

Eta12-40 ug/mL EthionamidecellWall

0.613

INH0.2-0.4 ug/mL IsoniazidcellWall

0.362

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.398

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.661

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.089

BZA0.12 mg/mL BenzamidearomaticAmides

-0.132

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.061

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.101

H2O24 mM hydrogen peroxideDNAdamaging

0.644

Levo10 ug/mL LevofloxacinDNAdamaging

0.776

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.170

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.979

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.886

UVUV-irradiationDNAdamaging

-0.836

ARP41-4 ug/mL Antitubercular compound ARP4?

0.628

Antimycin12.5-50 ug/mL Antimycin A?

0.752

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.441

PA_110-50 ug/mL Antitubercular compound PA-1?

0.429

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.956

PA8240.2-2 ug/mL PA-824?

-1.043

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.582

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.251

Verapamil50 uM Verapamil?

0.399

mercaptoethanol2 mM 2-Mercaptoethanol?

0.780

methoxatin10-20 ug/mL Methoxatin?